Skip to main content
FinSpry Logo
FinSpry
TCRX logo
TCRX
(NASDAQ)
TScan Therapeutics, Inc.
$0.34-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

TScan Therapeutics (TCRX) Stock Price & Financial Analysis

TScan Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.33 - $0.38
52-Week High$2.57
52-Week Low$0.33
Open$0.38
Volume1.53M
Average Volume (3M)801.47K
Market Cap50.86M
Shares Outstanding129.91M
Price to Sales (P/S)5.57
Price to Book (P/B)0.52
EV/EBITDA-0.23
Revenue (TTM)9.14M
Net Income (TTM)-124.31M
Free Cash Flow (TTM)-124.96M
EPS (TTM)$-0.96
Profit Margin-1360.61%
Operating Margin-1408.73%
Return on Equity (ROE)-128.25%
Debt to Equity1.08
50-Day MA$0.82
200-Day MA$1.00
52-Week Change-81.66%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About TScan Therapeutics

What is the current stock price for TCRX?

As of the latest trading session, TCRX stock trades at $0.34. The 52-week range is $0.33–$2.57, with a day range of $0.33–$0.38.

What is the P/E ratio for TCRX?

The P/E ratio (Price-to-Earnings) for TCRX is shown in the Key Statistics section. This valuation metric helps compare TScan Therapeutics, Inc. to industry peers.

Does TCRX pay dividends?

TScan Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TCRX?

Based on 5 analysts, the consensus for TCRX is Buy.

What is the market cap of TCRX?

TScan Therapeutics's market capitalization is $44.8M, classifying it as a micro-cap company. TScan Therapeutics operates in the Healthcare sector within the Biotechnology industry.